<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2904257310
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1999
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        CONCOR 5 PLUS F.C. TABLETS
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        HYDROCHLOROTHIAZIDE,BISOPROLOL FUMARATE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        12.5,5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Film-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        19.5
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="MERCK HEALTHCARE KGAA" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            MERCK HEALTHCARE KGAA
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 606]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            ALHAYA MEDICAL CO
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Merck Healthcare KGAA
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        C07BB07
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Concor 5 plus is for High blood pressure (hypertension) The combination preparation Concor 5 plus is recommended only if therapy with one of the individual active substances, bisoprolol or hydrochlorothiazide with which management of high blood pressure should first be attempted - was inadequately effective and the dosage of the individual active substances as present in the Concor 5 plus combination has proven to be appropriate</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr">What you need to know before you use Concor 5 plus<br />Do not use Concor 5 plus:<br />- Myocardial insufficiency (congestive heart failure)<br />- Shock<br />- disturbances of atrioventricular conduction (2nd and 3rd degree AV block)<br />- sick sinus syndrome<br />- disturbance of sinoatrial conduction (sinoatrial block)<br />- markedly slowed heart rate (pulse less than 50 beats/min) before the start of treatment<br />- accumulation of acid in the blood (acidosis)<br />- tendency to bronchospasm (e.g. in bronchial asthma)<br />- late stages of peripheral circulatory disturbances<br />- concomitant administration of MAO inhibitors (exception: MAO-B inhibitors)<br />- severe disturbances of kidney function (renal insufficiency with severely impaired or absent urine production<br />- creatinine clearance less than 30 ml/min and/or serum creatinine values over 1.8 mg/100 ml)<br />- acute inflammation of the kidney (glomerulonephritis),<br />- liver failure involving disturbed consciousness (coma and hepatic precoma)<br />- potassium deficiency states (hypokalemia) not responding to treatment<br />- severe sodium deficiency states (severe hyponatremia)<br />- increased calcium concentrations in the blood (hypercalcemia)<br />- gout, hypersensitivity to hydrochlorothiazide and other thiazides<br />- Sulphonamides or betablockers<br />- children (no therapeutic experience)<br />- The intravenous administration of calcium antagonists of the verapamil and diltiazem type or other antiarrhythmics (such as disopyramide) in patients undergoing treatment with Concor 5 plus is contraindicated (exception: intensive care medicine).</p><p dir="ltr">Concor 5 plus must not be used during pregnancy and the nursing period.<br />Warnings and precautions<br />Drugs that contain beta-blockers can increase the sensitivity to allergens and the severity of Anaphylactic reactions, i.e. acute general allergic reactions.<br />In patients with a history of severe hypersensitivity reactions and in patients undergoing therapy to<br />reduce or eliminate the tendency towards allergic reactions (desensitization therapy) this may result<br />in excessive anaphylactic reactions; beware of this when administering this drug.<br />In severely impaired hepatic and renal function, elimination of the HCT proportion contained in<br />Concor 5 plus is reduced due to which dose reduction may become necessary (see dosage instructions).<br />The warning signs of reduced blood glucose (hypoglycemia) may be masked making regular monitoring of blood glucose necessary. During long-term therapy with Concor 5 plus the<br />serum electrolytes (especially potassium, sodium, calcium), creatinine and urea, serum lipids (cholesterol and triglycerides), and uric acid should be monitored regularly. The possibility of reduced lacrimation is to be borne in mind if contact lenses are worn.<br />During treatment with Concor 5 plus patients should ensure an adequate supply of fluid and food<br />rich in potassium (e.g. bananas, vegetables, nuts) to compensate for the increased loss of potassium.<br />The potassium losses may be reduced or prevented by concomitant therapy with potassium-sparing<br />diuretics.<br />if you have had skin cancer or if you develop an unexpected skin lesion during the treatment. Treatment with hydrochlorothiazide, particularly long-term use with high doses, may increase the risk of some types of skin and lip cancer (non-melanoma skin cancer). Protect your skin from sun exposure and UV rays while taking Concor 5 plus<br />Other medicines and Concor 5 plus<br />Tell your doctor or pharmacist if you are using, have recently used or might use any other medicines.<br />During treatment with Concor 5 plus and with concomitant administration of ACE inhibitors (e.g. Captopril, enalapril) there is the risk of an excessive decrease in blood pressure at the start of therapy.<br />The concomitant administration of Concor 5 plus and insulin or oral antidiabetics may potentiate or prolong or else attenuate their effect. Warning signs of reduced blood glucose (hypoglycemia), especially accelerated pulse (tachycardia) and tremor, can be masked or attenuated. Therefore, regular monitoring of blood glucose is necessary.</p><p dir="ltr">Salicylates and other non-steroidal anti-inflammatory drugs (e.g. indomethacin) may attenuate the antihypertensive and diuretic effects of Concor 5 plus. In high-dose salicylate administration the toxic effect of salicylates on the central nervous system may be potentiated. In patients with decreasing volume of circulating blood (hypovolemia) under Concor 5 plus therapy the concomitant administration of non-steroidal anti-inflammatory drugs can trigger acute renal failure.<br />The antihypertensive effect of Concor 5 plus may be potentiated by other antihypertensive drugs, barbiturates, phenothiazines, tricyclic antidepressants, vasodilators, or alcohol.<br />The concomitant administration of Concor 5 plus and calcium antagonists of the nifedipine type may<br />lead to a pronounced drop in blood pressure and, in individual cases, to the development of heart failure.<br />An addition of the cardio depressant effects of Concor 5 plus and antiarrhythmics is possible.<br />In concurrent use of Concor 5 plus and calcium antagonists of the verapamil or diltiazem type or<br />other antiarrhythmics (such as disopyramide) patients should be closely monitored since hypotension,<br />bradycardia or other cardiac arrhythmias may occur.<br />The concomitant administration of Concor 5 plus, reserpine, alpha-methyldopa, guanfacine or clonidine may lead to an excessive decrease in heart rate or to delayed cardiac conduction.<br />The abrupt withdrawal of clonidine in concomitant administration of Concor 5 plus may lead to an excessive rise in blood pressure. Therefore, clonidine must not be withdrawn unless the use of Concor<br />5 plus was stopped some days previously. This may be then followed by the step-wise withdrawal of<br />clonidine.<br />The concurrent use of Concor 5 plus and noradrenaline, adrenaline or other sympathomimetic compounds (e.g. contained in cough preparations, nose and eye drops) may lead to a rise in blood pressure.<br />Monoaminoxidase (MAO) inhibitors should not be taken simultaneously with Concor 5 plus due to the possibility of excessive hypertension.<br />The effect of uric-acid-lowering agents may be attenuated in concomitant administration of<br />Concor 5 plus.<br />In concurrent therapy with cardiac glycosides it should be borne in mind that in potassium deficiency<br />(hypokalemia) and/or magnesium deficiency (hypomagnesaemia) developing during treatment<br />with Concor 5 plus the heart muscle shows increased sensitivity to cardiac glycosides, thus leading to<br />a potentiation of their effects and adverse reactions.<br />The concurrent administration of ergotamine derivatives (e.g. ergotamine-containing drugs against<br />migraine) and Concor 5 plus may exacerbate peripheral circulatory disturbances.<br />The concurrent use of Concor 5 plus and glucocorticoids, ACTH, carbenoxolone, amphotericin B, frusemide or laxatives may result in elevated potassium losses.<br />The concomitant administration of Concor 5 plus and lithium potentiates the damaging effects of lithium on heart and nerves (cardiotoxic and neurotoxic effects) through a reduction of lithium excretion.<br />The concurrent administration of Concor 5 plus and anesthetics may lead to a pronounced drop in<br />blood pressure. These two agents may have additive cardio depressant (negative inotropic) effects.</p><p dir="ltr">The effect of curare-type muscle relaxants may be potentiated or prolonged by Concor 5 plus.<br />Should it not be possible to withdraw Concor 5 plus prior to surgery under general anesthesia or prior<br />to use of curare-type muscle relaxants, the anesthetist should be informed that the patient is being<br />treated with Concor 5 plus.<br />In concomitant administration of cytostatic (e.g. Cyclophosphamide, fluorouracil, methotrexate)<br />increased bone marrow toxicity is to be expected.<br />Rifampicin may reduce the antihypertensive effect of Concor 5 plus.<br />The antihypertensive effect of Concor 5 plus may be potentiated by cimetidine.<br />Concor 5 plus may reduce the excretion of lidocaine.<br />The concomitant administration of cholestyramine or colestipol reduces the absorption of the hydrochlorothiazide component of Concor 5 plus.<br />In concurrent use of methyldopa hemolysis due to the formation of antibodies to hydrochlorothiazide<br />has been described in isolated cases.<br />The intravenous administration of calcium antagonists of the verapamil and diltiazem type or other<br />antiarrhythmics (such as disopyramide) in patients undergoing treatment with Concor 5 plus is contraindicated (exception: intensive care medicine).<br />Pregnancy and breast feeding<br />Concor 5 plus must not be used during pregnancy due to suspected thrombocytopenia in newborns.<br />Use of Concor 5 plus during the nursing period is contraindicated since the active substance hydrochlorothiazide can inhibit milk production. If use during this period is essential, breast-feeding<br />should be avoided.<br />Driving and using machines<br />The treatment of hypertension with this drug requires regular monitoring by the physician. The occurrence of reactions varying from one individual to another may impair the ability to drive a vehicle, to operate machinery, or to work without a firm hold. This is particularly the case at the start of treatment, when the dosage is increased or the medication changed, as well as in conjunction with<br />alcohol.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr">The following dosage instructions apply for Concor 5 plus, unless your doctor has prescribed otherwise.<br />Please follow these directions carefully, otherwise Concor 5 plus cannot have the proper effect.<br />Dosage<br />The treatment of high blood pressure should principally be started with low doses of a single active<br />substance and then increased gradually. The fixed combination of Concor 5 plus consisting of bisoprolol and hydrochlorothiazide should be administered only if the blood pressure could not be normalized by the individual active substances or else excessive adverse reactions had occurred at high doses, and the dosage of the individual active substances as present in the Concor 5 plus combination has proven to be appropriate. The dosage must not be altered without the doctor&#39;s direction.</p><p dir="ltr">If not prescribed otherwise,<br />1- take 1 film-coated tablet of Concor 5 plus (5 mg bisoprolol fumarate<br />(2:1) and 12.5 mg hydrochlorothiazide) once daily.<br />2- If the blood pressure is only inadequately reduced the dose may be increased to 2 film-coated tablets of Concor 5 plus (equivalent to 10 mg bisoprolol fumarate (2:1) and 25 mg hydrochlorothiazide) once daily.<br />3- In co-existing impairment of kidney and/or liver function, the dose of 5 mg bisoprolol fumarate<br />(2:1) + 12.5 mg hydrochlorothiazide should not be exceeded.<br />Method and route of administration<br />The doctor decides on the duration of treatment. It depends upon the nature and severity of the disease. The dose of Concor 5 plus must not be altered or therapy discontinued without the doctor&#39;s direction. After long-term therapy - particularly in the presence of ischemic heart disease - Concor 5 plus should be discontinued gradually (i.e. over 7-10 days), since abrupt withdrawal may lead to an acute deterioration of the patient&#39;s condition.<br />The film-coated tablets are to be swallowed whole with the breakfast with some liquid.<br />If you use more Concor 5 plus than you should<br />Please inform your doctor.<br />In the event of overdosage or a precarious drop in heart rate (pulse) and/or blood pressure the therapy<br />with Concor 5 plus must be discontinued immediately.<br />In overdosage the cardio depressant effect predominates with slowing of the pulse.<br />Shortness of breath may be caused by bronchospasms. As a result of fluid losses, thirst, weakness, dizziness, muscle pain, increased heart rate, circulatory collapse, acute renal failure, cardiac arrhythmias and constipation to the point of ileus may occur.<br />If necessary, the following antidotes should be administered alone or consecutively: - Intravenous<br />atropine 0.5-2.0 mg as bolus injection - Intravenous glucagon initially 1-10 mg, thereafter 2-2.5 mg per hour as continuous infusion.<br />- Orciprenaline by slow intravenous injection until the onset of effect.<br />- In the event of convulsions intravenous diazepam should be administered slowly.<br />- Fluid and potassium substitution may be necessary.<br />- Should bronchospasms occur, bronchodilators may be administered, e.g. fenoterol or salbutamol as aerosol.<br />If you forget to use Concor 5 plus<br />Take the normal dose again the next morning.<br />If you stop taking Concor 5 plus<br />Treatment with Concor 5 plus must not be stopped abruptly but must always be discontinued gradually.<br />This is to be borne in mind particularly in patients with diseases of the coronary vessels. The dosage of<br />this drug must never be changed without the doctor&#39;s direction.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr">Like all medicines, this medicine can cause side effects, although not everybody gets them.</p><p dir="ltr">Tell your doctor immediately if you experience strong and recurrent headaches associated with feeling sick (nausea), vomiting or sight disturbances. These are symptoms of a side effect called benign intracranial hypertension and it is uncommon.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><strong>Side</strong><strong> effects may occur with certain frequencies, which are defined as follows:</strong></p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; very common: may affect more than 1 in 10 people</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; common: may affect up to 1 in 10&nbsp;people</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; uncommon: may affect up to 1 in 100&nbsp;people</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; rare: may affect up to 1 in 1,000&nbsp;people</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; very rare: may affect up to 1&nbsp;in 10,000 people</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; not known frequency cannot be estimated from the available data.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Common side effects:</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hyperglycemia</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hyperuricemia</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Disturbances of the fluid and electrolyte balance (in particular hypokalemia and hyponatremia, also hypomagnesaemia and hypochloridemia as well as hypercalcemia)</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dizziness</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Headache</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Sensation of cold or numb extremities</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Nausea</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Vomiting</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Diarrhea</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Constipation</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fatigue</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Increased triglyceride and cholesterol levels</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Glucosuria</p><p dir="ltr">&nbsp;</p><p dir="ltr">Uncommon side effects:</p><p dir="ltr">&nbsp;</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Sleep disorders</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Depression</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Loss of appetite</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bradycardia</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; AV-conduction disturbances</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Deterioration of existing heart failure</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Orthostatic dysregulation</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bronchospasm in patients with a history of bronchial asthma or obstructive airways disease</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Abdominal ailments</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pancreatitis</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Muscle weakness and cramps</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Asthenia</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Increase in amylase</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reversible increase in serum creatinine and urea</p><p dir="ltr">Rare side effects:</p><p dir="ltr">&nbsp;</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Increase in liver enzymes (ASAT, ALAT)</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Potency disorders</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hypersensitivity reactions (itching, flush, rash, photodermatitis, purpura, urticaria) You should see a doctor straight away if you experience more severe allergic reactions, which may involve face, neck, tongue, mouth or throat swelling, or difficulty breathing.</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hepatitis</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Jaundice</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Allergic rhinitis</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Syncope</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hearing disorders</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reduced tear flow (to be taken into consideration in patients wearing contact lenses)</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Visual disturbances</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Nightmares, hallucinations</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Leucopenia</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Thrombocytopenia</p><p dir="ltr">Very rare side effects:</p><p dir="ltr">&nbsp;</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Agranulocytosis</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Metabolic alkalosis</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Conjunctivitis</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Beta-blockers can trigger psoriasis, aggravate the condition or lead to psoriasiform rash, hair loss or cutaneous lupus erythematosus</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Chest pain</p><p dir="ltr">&nbsp;</p><p dir="ltr">Side effects with an unknown frequency</p><p dir="ltr">&nbsp;</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interstitial lung disease</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Non-melanoma skin cancer (Basal cell carcinoma and Squamous cell carcinoma).</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; short-sightedness</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; decrease in vision or pain in your eyes due to high pressure (possible signs of fluid accumulation in the vascular layer of the eye (choroidal effusion) or acute angle-closure glaucoma)</p><p dir="ltr">&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr">Keep this medicine out of the sight and reach of children<br />&bull; Do not use this medicine after the expiry date which is stated on the blister and the carton after EXP. The expiry date refers to the last date of that month.<br />&bull; Store below 30 &deg;C<br />&bull; This medicine does not require any special storage conditions.<br />Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr">Concor 5 plus film-coated tablets.:<br />&bull; active substance is bisoprolol fumarate and hydrochlorothiazide Each film-coated tablet contains 5 mg bisoprolol fumarate (2:1) and12.5 mg hydrochlorothiazide.<br />&bull; The other ingredients are:<br />- Colloidal silicon dioxide, magnesium stearate, microcrystalline cellulose, corn starch, calcium hydrogen phosphate, dimethicone 100, macrogol 400, methyl hydroxypropyl cellulose, colorings E 171, E 172.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Film-coated tablets, heart-shaped, with dividing score
Packs of 20 tablets
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr">Marketing Authorization Holder and Manufacturer</p><p dir="ltr">Merck Healthcare KGaA<br />Frankfurter Strasse 250<br />64293 Darmstadt<br />Germany</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Nov 2020 
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>كونكور 5 بلس مخصص لارتفاع ضغط الدم (ارتفاع الضغط). ينصح باستخدام المستحضر المركب كونكور 5 بلس فقط إذا كان العلاج بإحدى المواد الفعالة الفردية، بيزوبرولول أو هيدروكلوروثيازيد والذي يجب أن تتم تجربته أولاً للسيطرة على ارتفاع ضغط الدم - غير فعال بشكل كافِ، وقد أثبتت جرعة المواد الفعالة الفردية كتلك الموجودة في مجموعة كونكور 5 بلس أنها مناسبة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>موانع استخدام كونكور 5 بلس:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قصور عضلة القلب (فشل القلب الاحتقاني)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الصدمة</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اضطرابات التوصيل الأذيني البطيني (الانسداد الأذيني البطيني AV من الدرجة الثانية والثالثة)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; متلازمة العقدة الجيبية المريضة</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اضطراب التوصيلية الجيبية الأذينية (الانسداد الجيبي الأذيني)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التباطؤ الملحوظ في معدل ضربات القلب (نبض أقل من 50 نبضة/دقيقة) قبل بدء العلاج</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تراكم الحمض في الدم (الحُمَاض)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; وجود ميل إلى تشنج قصبي (مثل الربو القصبي)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المراحل المتأخرة من اضطرابات الدورة الدموية الطرفية</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إعطاء مثبطات أكسيداز أحادي الأمين MAO بشكل مصاحب (باستثناء: مثبطات MAO-B)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الاضطرابات الحادة في وظائف الكلى (قصور كلوي مع خلل شديد أو عدم إخراج البول</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تصفية كرياتينين أقل من 30 مل/دقيقة و/أو قيم الكرياتينين في المصل تزيد عن 1.8 ملغم/100 مل)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الالتهاب الحاد في الكلى (التهاب كبيبات الكلى)،</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فشل الكبد الذي ينطوي على اضطراب الوعي (الغيبوبة ومقدمات الغيبوبة الكبدية)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حالات نقص البوتاسيوم (نقص البوتاسيوم في الدم) التي لا تستجيب للعلاج</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حالات نقص الصوديوم الشديد (نقص الصوديوم الشديد في الدم)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة تركيزات الكالسيوم في الدم (فرط الكالسيوم في الدم)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; النقرس، فرط الحساسية للهيدروكلوروثيازيد والثيازيدات الأخرى</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; السلفوناميدات أو حاصرات البيتا</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأطفال (لا توجد خبرة علاجية)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يمنع إعطاء مضادات الكالسيوم من نوع فيراباميل وديلتيازيم أو غيرها من مضادات عدم انتظام ضربات القلب (مثل ديسوبيراميد) عن طريق الوريد في المرضى الذين يخضعون للعلاج بكونكور 5 بلس (استثناء: طب العناية المركزة).</p><p>يجب عدم استخدام كونكور 5 بلس أثناء الحمل وفترة الرضاعة.</p><p>التحذيرات والاحتياطات</p><p>يمكن للأدوية التي تحتوي على حاصرات بيتا أن تزيد من الحساسية لمسببات الحساسية وشدة تفاعلات الحساسية، أي تفاعلات الحساسية العامة الحادة.</p><p>في المرضى الذين لديهم تاريخ من تفاعلات فرط الحساسية الشديدة وفي المرضى الذين يخضعون للعلاج لتقليل أو القضاء على الميل نحو ردود الفعل التحسسية (علاج الحساسية) قد ينتج عن ذلك تفاعلات الحساسية المفرطة؛ كن على دراية بذلك عند إعطاء هذا العقار.</p><p>في حالة وجود قصور شديد في وظائف الكبد والكلى، يتم تقليل التخلص من نسبة الهيماتوكريت HCT الموجودة في كونكور 5 بلس نظرًا لأن تخفيض الجرعة قد يصبح ضروريًا (انظر تعليمات الجرعة).</p><p>العلامات التحذيرية لانخفاض السكر في الدم قد لا تكون ظاهرة مما يجعل المراقبة المنتظمة لنسبة الجلوكوز في الدم أمرًا ضروريًا. أثناء العلاج طويل الأمد بكونكور 5 بلس، يجب مراقبة الشوارد المصلية (وخاصة البوتاسيوم والصوديوم والكالسيوم) والكرياتينين واليوريا، ومصل الدهون في الدم (الكوليسترول والدهون الثلاثية)، وحمض اليوريك بانتظام. يجب مراعاة إمكانية حدوث نقص في إفراز الدموع في حالة ارتداء العدسات اللاصقة.</p><p>أثناء العلاج بكونكور 5 بلس يجب أن يضمن المرضى الحصول على قدر كافِ من السوائل والمواد الغذائية الغنية بالبوتاسيوم (مثل الموز والخضروات والمكسرات) للتعويض عن زيادة فقدان البوتاسيوم. قد يتم تقليل أو منع فقدان البوتاسيوم عن طريق العلاج المصاحب بمدرات البول التي توفر من البوتاسيوم.</p><p>إذا كنت قد أصبت بسرطان الجلد أو إذا أصبت بآفة جلدية غير متوقعة أثناء العلاج. قد يؤدي العلاج باستخدام هيدروكلوروثيازيد، خاصةً الاستخدام طويل الأمد بجرعات عالية، إلى زيادة خطر الإصابة ببعض أنواع سرطان الجلد والشفة (سرطان الجلد غير الميلاني). احم بشرتك من التعرض لأشعة الشمس والأشعة فوق البنفسجية أثناء تناول كونكور 5 بلس</p><p>الأدوية الأخرى وكونكور 5 بلس</p><p>أخبر طبيبك أو الصيدلي إذا كنت تتناول أي أدوية أخرى أو تناولتها مؤخرًا أو ربما تتناولها في المستقبل.</p><p>أثناء العلاج باستخدام كونكور 5 بلس ومع إعطاء مثبطات الإنزيم المحول للأنجيوتنسين (مثل كابتوبريل، إينالابريل) بشكل مصاحب، هناك خطر حدوث انخفاض مفرط في ضغط الدم في بداية العلاج.</p><p>إعطاء كونكور 5 بلس والإنسولين أو مضادات السكر عن طريق الفم بشكل مصاحب قد تعزز أو تطيل أو تخفف من تأثيرها. العلامات التحذيرية لانخفاض نسبة السكر في الدم (نقص السكر في الدم)، وخاصة النبض المتسارع (عدم انتظام دقات القلب) والرعشة، يمكن أن تكون خفية أو مخففة. لذلك، من الضروري إجراء مراقبة منتظمة لنسبة الجلوكوز في الدم.</p><p>إن الساليسيلات وغيرها من الأدوية المضادة للالتهابات غير الستيرويدية (على سبيل المثال الإندوميتاسين) قد تخفف من التأثيرات الخافضة للضغط ومدرة للبول في كونكور 5 بلس. في تناول جرعة عالية من الساليسيلات، قد يكون التأثير السام للساليسيلات على الجهاز العصبي المركزي قويًا. في المرضى الذين يعانون من تناقص حجم الدم الساري (نقص حجم الدم) تحت علاج كونكور 5 بلس، يمكن أن يؤدي إعطاء العقاقير المضادة للالتهابات غير الستيرويدية المصاحبة إلى فشل كلوي حاد.</p><p>قد يزيد التأثير الخافض للضغط في كونكور 5 بلس بفعل العقاقير الخافضة للضغط الأخرى أو الباربيتورات أو الفينوثيازينات أو مضادات الاكتئاب ثلاثية الحلقات أو موسعات الأوعية أو الكحول.</p><p>إعطاء الكونكور 5 بلس ومضادات الكالسيوم المصاحبة من النوع النيفيديبين قد تؤدي إلى انخفاض واضح في ضغط الدم، في حالات فردية، إلى حدوث فشل القلب.</p><p>من الممكن إضافة تأثيرات اكتئاب القلب الناتجة عن كونكور 5 بلس وخفض اضطراب ضربات القلب.</p><p>في الاستخدام المتزامن لكونكور 5 بلس ومضادات الكالسيوم من نوع الفيراباميل أو الديلتيازيم أو غيرهم من مضادات عدم انتظام ضربات القلب (مثل ديسوبيراميد)، يجب مراقبة المرضى عن كثب لأن انخفاض ضغط الدم أو بطء القلب أو اضطرابات نظم القلب الأخرى قد تحدث.</p><p>إعطاء كونكور 5 بلس أو ريزيربين أو ألفا ميثيل دوبا أو جوانفاسين أو كلونيدين المتصاحب قد يؤدي إلى انخفاض مفرط في معدل ضربات القلب أو تأخر توصيل القلب.</p><p>السحب المفاجئ للكلونيدين في العلاج المصاحب للكونكور 5 بلس قد يؤدي إلى زيادة مفرطة في ضغط الدم. لذلك، ممنوع سحب الكلونيدين إلا إذا تم إيقاف استخدام كونكور 5 بلس قبل بضعة أيام. قد يتبع ذلك سحب الكلونيدين خطوة خطوة.</p><p>إن الاستخدام المتزامن لكونكور 5 بلس والنورأدرينالين أو الأدرينالين أو غيرها من المركبات محاكية العصب الودي (مثل تلك الموجودة في مستحضرات السعال وقطرات الأنف والعين) قد يؤدي إلى ارتفاع في ضغط الدم.</p><p>لا ينبغي أن تؤخذ مثبطات أكسيداز أحادي الأمين MAO في وقت واحد مع كونكور 5 بلس بسبب احتمال ارتفاع ضغط الدم المفرط.</p><p>قد يحدث تخفيف لتأثير عوامل خفض حمض اليوريك عند إعطاء الكونكور 5 بلس بشكل مصاحب مع أدوية أخرى.</p><p>في العلاج المتزامن مع جليكوسيدات القلب، يجب أن يؤخذ في الاعتبار أنه في حالة نقص البوتاسيوم في الدم و/أو نقص المغنيسيوم في الدم والتي تتنامى أثناء العلاج بكونكور 5 بلس تُظْهِر عضلة القلب زيادة حساسية للجليكوسيدات القلبية، مما يؤدي إلى زيادة فعالية آثارها وردود الفعل السلبية.</p><p>الإعطاء المتزامن لمشتقات الإرغوتامين (مثل الأدوية المحتوية على الإرغوتامين ضد الصداع النصفي) وكونكور 5 بلس قد يؤدي إلى تفاقم الاضطرابات في الدورة الدموية الطرفية.</p><p>إن الاستخدام المتزامن لكونكور 5 بلس والجلوكوكورتيكويدات أو ACTH أو كربينوكسولون أو الأمفوتريسين ب أو فوروسيميد أو الملينات قد يؤدي إلى ارتفاع في نسبة فقد البوتاسيوم.</p><p>إعطاء كونكور 5 بلس بمصاحبة الليثيوم يعزز الآثار الضارة لليثيوم على القلب والأعصاب (تأثيرات السمية القلبية والسمية العصبية) من خلال تقليل إفراز الليثيوم.</p><p>قد يؤدي إعطاء كونكور 5 بلس مع أدوية التخدير إلى انخفاض واضح في ضغط الدم. قد يكون لهذين العاملين تأثيرات إضافية على الاكتئاب القلبي (مؤثرات التقلص العضلي السلبية).</p><p>قد يقوى أو يطول تأثير مرخيات العضلات المستخلصة من الكورار بواسطة كونكور 5 بلس.</p><p>إذا لم يكن من الممكن سحب كونكور 5 بلس قبل الجراحة تحت التخدير العام أو قبل استخدام مرخيات العضلات المستخلصة من الكورار، فيجب إخبار طبيب التخدير أن المريض يتم علاجه باستخدام كونكور 5 بلس.</p><p>عند إعطائه مع أدوية تثبيط الخلايا (مثل سيكلوفوسفاميد، فلورويوراسيل، الميثوتريكسيت) من المتوقع زيادة سُميِّة نخاع العظام.</p><p>ريفامبيسين قد يقلل من التأثير الخافض للضغط لكونكور 5 بلس.</p><p>التأثير الخافض للضغط في كونكور 5 بلس قد يقوى بسبب السيميتيدين. قد يقلل كونكور 5 بلس من إفراز ليدوكائين.</p><p>إعطاء العلاج بالاقتران مع كوليستيرامين أو كولستيبول يقلل من امتصاص مكون هيدروكلوروثيازيد في كونكور 5 بلس.</p><p>الاستخدام المتزامن لانحلال الميثيلدوبا بسبب تكون أجسام مضادة للهيدروكلوروثيازيد قد تم وصفه في حالات فردية.</p><p>يمنع إعطاء مضادات الكالسيوم من نوع فيراباميل وديلتيازيم أو غيرها من مضادات عدم انتظام ضربات القلب (مثل ديسوبيراميد) عن طريق الوريد في المرضى الذين يخضعون للعلاج بكونكور 5 بلس (استثناء: طب العناية المركزة).</p><p>الحمل والإرضاع الطبيعي</p><p>يجب عدم استخدام كونكور 5 بلس أثناء الحمل بسبب نقص الصفيحات المشتبه به عند حديثي الولادة. يمنع استخدام كونكور 5 بلس خلال فترة الإرضاع لأن المادة الفعالة هيدروكلوروثيازيد يمكن أن تثبط إنتاج الحليب. إذا كان استخدامه خلال هذه الفترة ضروريًا، فيجب تجنب الرضاعة الطبيعية.</p><p>القيادة واستعمال الآلات</p><p>علاج ارتفاع ضغط الدم مع هذا الدواء يتطلب مراقبة منتظمة من قبل الطبيب. إن حدوث ردود فعل متباينة من فرد لآخر قد يضعف القدرة على قيادة مركبة أو تشغيل الآلات أو العمل دون أدوات تعليق ثابتة. ويكون هذا هو الحال بشكل خاص في بداية العلاج، عندما يتم زيادة الجرعة أو تغيير الدواء، وكذلك بالتزامن مع الكحول</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>تنطبق التعليمات التالية الخاصة بالجرعات على كونكور 5 بلس، ما لم يصف طبيبك غير ذلك. يرجى اتباع هذه الإرشادات بعناية، وإلا فلن يكون لكونكور 5 بلس التأثير الصحيح.</p><p>الجرعات</p><p>يجب أن يبدأ علاج ارتفاع ضغط الدم بشكل أساسي بجرعات منخفضة من مادة فعالة واحدة ثم يزداد تدريجيًا. يجب إعطاء التركيبة الثابتة من كونكور 5 بلس المكونة من بيزوبرولول وهيدروكلوروثيازيد فقط إذا كان من غير الممكن جعل ضغط الدم طبيعيًا بواسطة المواد الفعالة الفردية أو حدثت تفاعلات ضارة مفرطة أخرى مع الجرعات العالية، وقد أثبتت جرعة المواد الفعالة الفردية الموجودة في مجموعة كونكور 5 بلس أنها مناسبة. ممنوع تغيير الجرعة بدون توجيه من الطبيب.</p><p>إذا لم يُوصَف خلاف ذلك،</p><p>1-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; خذ قرصًا واحدًا مغلفًا من كونكور 5 بلس (5 ملغ بيزوبرولول فومارات (2:1) و 12.5 ملغ من هيدروكلوروثيازيد) مرة واحدة يوميًا.</p><p>2-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا انخفض ضغط الدم بشكل غير كافٍ، يمكن زيادة الجرعة إلى قرصين مغلفين من كونكور 5 بلس (أي ما يعادل 10 ملغ بيزوبرولول فومارات (2:1) و 25 ملغ هيدروكلوروثيازيد) مرة واحدة يوميًا.</p><p>3-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; في الاختلال المشترك لوظائف الكلى و/أو الكبد، يجب عدم تجاوز جرعة 5 ملغ بيزوبرولول فومارات (2:1) + 12.5 ملغ من هيدروكلوروثيازيد.</p><p>طريقة ومسار إعطاء الدواء</p><p>الطبيب هو من يقرر مدة العلاج. يعتمد ذلك على طبيعة وشدة المرض. يجب عدم تغيير جرعة كونكور 5 بلس أو إيقاف العلاج دون توجيه من الطبيب. بعد العلاج طويل الأمد - وخاصة في حالة الإصابة بأمراض نقص تروية القلب - يجب إيقاف كونكور 5 بلس بشكل تدريجي (أي أكثر من 7-10 أيام)، لأن السحب المفاجئ قد يؤدي إلى تدهور حاد في حالة المريض.</p><p>يجب ابتلاع الأقراص المغلفة بالكامل مع وجبة الإفطار مع سائل.</p><p>إذا استخدمت كونكور 5 بلس أكثر مما يجب</p><p>يرجى إبلاغ طبيبك.</p><p>في حالة الجرعة الزائدة أو انخفاض غير مستقر في معدل ضربات القلب (النبض) و/أو ضغط الدم، يجب وقف العلاج بكونكور 5 بلس على الفور.</p><p>في حالة الجرعة الزائدة، يسود تأثير اكتئاب القلب مع إبطاء النبض.</p><p>قد يكون ضيق التنفس بسبب تشنجات القصبات الهوائية. نتيجة لفقدان السوائل، قد يحدث عطش، ضعف، دوخة، ألم عضلي، زيادة معدل ضربات القلب، انهيار الدورة الدموية، الفشل الكلوي الحاد، عدم انتظام ضربات القلب والإمساك حتى نقطة العلوص (انسداد الأمعاء).</p><p>إذا لزم الأمر، ينبغي إعطاء الترياقات التالية منفردة أو على التوالي: - الأتروبين عن طريق الوريد 2.0-0.5 ملغ كحقن على مدار فترة زمنية معينة - الجلوكاجون في الوريد في البداية 10-1 ملغ، وبعد ذلك 2.5-2 ملغ في الساعة كتسريب مستمر.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أورسيبرينالين عن طريق الحقن في الوريد ببطء حتى ظهور التأثير.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; في حالة حدوث التشنجات، يجب إعطاء الديازيبام في الوريد ببطء.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قد يكون من الضروري استبدال السوائل والبوتاسيوم.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; في حالة حدوث تشنج قصبي، يمكن إعطاء موسعات القصبات، على سبيل المثال فينوتيرول أو سالبوتامول كرذاذ حُلالةٌ هوائيّة.</p><p>إذا نسيت استخدام كونكور 5 بلس</p><p>خذ الجرعة العادية مرة أخرى في صباح اليوم التالي.</p><p>إذا توقفت عن تناول كونكور 5 بلس</p><p>يجب ألا تتوقف المعالجة باستخدام كونكور 5 بلس بشكل مفاجئ وإنما يجب أن تتوقف دائمًا بشكل تدريجي.</p><p>يجب أن يؤخذ هذا في الاعتبار خاصة في المرضى الذين يعانون من أمراض الأوعية التاجية. يجب ألا تتغير جرعة هذا الدواء أبدًا دون توجيه من الطبيب.</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">شأنه شأن كل الأدوية، يمكن أن يسبب هذا الدواء آثارًا جانبية على الرغم من أنها لا تصيب جميع من يتناوله.</p><p>أخبر طبيبك على الفور إذا كنت تعاني من صداع قوي ومتكرر يرتبط بالشعور بالغثيان أو القيء أو اضطرابات الرؤية. هذه هي أعراض الآثار الجانبية التي تسمى ارتفاع ضغط الدم داخل الجمجمة الحميد وهي غير شائعة.</p><p dir="RTL"><strong>قد تحدث آثار جانبية بمرات تكرار معينة، والتي يتم تعريفها على النحو التالي:</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشائعة جدًا: قد تصيب أكثر من 1&nbsp;من كل 10&nbsp;أشخاص</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشائعة: قد تصيب حتى 1&nbsp;من كل 10&nbsp;أشخاص</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; غير الشائعة: قد تصيب حتى 1&nbsp;من كل 100&nbsp;شخص</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; النادرة: قد تصيب حتى 1&nbsp;من كل 1000&nbsp;شخص</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; النادرة جدًا: قد تصيب حتى 1&nbsp;من كل 10000&nbsp;شخص</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; غير معروفة: لا يمكن تقدير عدد المرات من البيانات المتوفرة.</p><p dir="RTL"><strong>الآثار الجانبية الشائعة:</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ارتفاع السكر في الدم</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فرط حمض اليوريك في الدم</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اضطرابات توازن السوائل والكهارل (خاصة نقص بوتاسيوم الدم ونقص صوديوم الدم، وكذلك نقص مغنيسيوم الدم ونقص كلوريد الدم وكذلك فرط كالسيوم الدم)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الدُوار</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الصداع</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الإحساس ببرودة أو خدر الأطراف</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الغثيان</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; القيء</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الإسهال</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الإمساك</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الإعياء</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة مستويات الدهون الثلاثية والكوليسترول</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; البيلة الغلوكوزية</p><p dir="RTL"><strong>الآثار الجانبية غير الشائعة:</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اضطرابات النوم</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الاكتئاب</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فقدان الشهية</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; بطء القلب</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اضطرابات التوصيل الأذيني البطيني AV</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تدهور فشل القلب القائم</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عدم انتظام الضغط الانتصابي</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التشنج القصبي في المرضى الذين لديهم تاريخ من الربو القصبي أو مرض انسداد الشعب الهوائية</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أمراض البطن</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب البنكرياس</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ضعف وتشنج العضلات</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فقد القوة</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الزيادة في أنزيم الإميليز</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة قابلة للعكس في كرياتينين المصل واليوريا</p><p>&nbsp;</p><p>&nbsp;</p><p dir="RTL"><strong>الآثار الجانبية النادرة:</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة في انزيمات الكبد (ASAT ، ALAT)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اضطرابات الفُحُولَة</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تفاعلات فرط الحساسية (الحكة، الاحمرار، الطفح الجلدي، التهاب الجلد الضوئي، الفرفرية، الشرى) , يجب أن ترى الطبيب على الفور إذا كنت تعاني من ردود فعل تحسسية أكثر حدة ، والتي قد تشمل تورم الوجه أو الرقبة أو اللسان أو الفم أو الحلق أو صعوبة التنفس.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب الكبد</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اليرقان</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب الأنف التحسسي</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الإغماء</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اضطرابات السمع</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض تدفق الدموع (يؤخذ في الاعتبار عند المرضى الذين يرتدون العدسات اللاصقة)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اضطرابات بصرية</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الكوابيس والهلاوس</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نقص كريات الدم البيضاء</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قلة الصفيحات</p><p dir="RTL"><strong>الآثار الجانبية النادرة جدًا:</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ندرة المحببات</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; القُلاءٌ الأيضي</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب الملتحمة</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حاصرات بيتا يمكن أن تؤدي إلى الصدفية، أو تؤدي إلى تفاقم الحالة أو تؤدي إلى طفح جلدي صدفي، أو تساقط الشعر، أو الذئبة الحمامية الجلدية</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم الصدر</p><p dir="RTL"><strong>الآثار الجانبية ذات التكرار غير المعروف</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مرض الرئة الخلالي</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سرطان الجلد اللاميلانومي (سرطان الخلايا القاعدية وسرطان الخلايا الحرشفية).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قصر النظر</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض في الرؤية أو ألم في عينيك بسبب ارتفاع الضغط (علامات محتملة لتراكم السوائل في طبقة الأوعية الدموية للعين (الانصباب المشيمي) أو زرق انسداد الزاوية الحاد)</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; احفظ هذا الدواء بعيدًا عن متناول الأطفال وأنظارهم</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تستخدم هذا العقار بعد تاريخ انتهاء صلاحيته المدون على الشريط والعلبة بعد الاختصار EXP (انتهاء الصلاحية). يشير تاريخ انتهاء الصلاحية إلى اليوم الأخير من الشهر المذكور.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يُحفَظ في درجة حرارة أقل من 30 درجة&nbsp;مئوية.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; هذا الدواء لا يتطلب أي ظروف تخزين خاصة.</p><p>لا ترمِ أيّ أدوية في مياه الصرف أو النفايات المنزلية. اسأل الصيدلي عن طريقة التخلص من الأدوية التي ما عدت تستعملها. تساعد هذه التدابير على حماية البيئة</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>كونكور 5 بلس أقراص مغلفة:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المادة الفعالة هي بيزوبرولول فومارات وهيدروكلوروثيازيد كل قرص مغلف يحتوي على 5 ملغ بيزوبرولول فومارات (2:1) و12.5 ملغ هيدروكلوروثيازيد.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المكونات الأخرى هي:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ثاني أكسيد السيليكون الغروي، ستيرات المغنيسيوم، سليولوز دقيق التبلور، نشا الذرة، فوسفات هيدروجين الكالسيوم، دايميثيكون 100، ماكروغول 400، ميثيل هيدروكسي بروبيل السليلوز، الأصباغ E 171 ، E 172.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>أقراص مغلفة، على شكل قلب، مع درجة تقسيم عُلب تحتوي على 20 قرصًا</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>&nbsp;</p><p>ت&zwnj;. الشركة المصنعة ومالك حق التسويق</p><p dir="ltr">&nbsp; &nbsp; &nbsp;</p><p dir="ltr">ميرك هيلث كير كي جي اي اي</p><p dir="ltr">، 250 فرانكفورتر شتراسه</p><p dir="ltr">دارمشتات ، 64293 ,</p><p dir="ltr">ألمانيا</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            نوفمبر 2020
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Concor® 5 plus, film-coated tablets
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Active substances: bisoprolol fumarate and hydrochlorothiazide 

Concor 5 plus:

One film-coated tablet contains 5.0 mg bisoprolol fumarate and 12.5 mg hydrochlorothiazide

For a full list of excipients, see section 6.1.


            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Film-coated tablet

Concor 5 plus are pink-white, heart-shaped, biconvex film-coated tablets with a spindle-shaped score on both sides. Tablet can be divided into equal halves.


            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Essential hypertension.</p><p dir="ltr">&nbsp;</p><p dir="ltr">The fixed dose combination Concor 5 plus resp. Concor 10 plus is indicated in patients whose blood pressure is not adequately controlled on bisoprolol or hydrochlorothiazide alone.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">&nbsp;</p><p dir="ltr">The fixed dose combinations (Concor 5 plus or Concor 10 plus) are indicated in patients whose blood pressure is not adequately controlled on bisoprolol fumarate or hydrochlorothiazide alone.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Individual dose titration with the single agents is recommended.</p><p dir="ltr">&nbsp;</p><p dir="ltr">When clinically appropriate, direct change from monotherapy to the fixed combination may be considered.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Renal impairment</em></p><p dir="ltr">&nbsp;</p><p dir="ltr">In co-existing impairment of kidney function the elimination of the HCTZ component of Concor 5 plus/Concor 10 plus is reduced, so that preference may have to be given to the lower dose form (Concor 5 plus) (see also section 4.4).</p><p dir="ltr"><em>Elderly patients</em></p><p dir="ltr"><em>&nbsp;</em></p><p dir="ltr">Principally, no dose adjustment is required.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Pediatric patients</em></p><p dir="ltr">&nbsp;</p><p dir="ltr">There is no pediatric experience with Concor 5 plus or Concor 10 plus therapy. Its use in children is therefore not recommended.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>method and duration of administration</em></p><p dir="ltr">&nbsp;</p><p dir="ltr">The film-coated tablets are to be swallowed whole with some liquid in the morning before, during or after breakfast.</p><p dir="ltr">&nbsp;</p><p dir="ltr">The duration of treatment is not limited. It depends upon the nature and severity of the disease.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Bisoprolol therapy should not be stopped abruptly, particularly not in patients with coronary heart disease, as this may lead to acute deterioration of the patient&#39;s state of health.</p><p dir="ltr">&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Concor 5 plus or Concor 10 plus must not be used in:

•	acute heart failure or during episodes of heart failure decompensation requiring i.v. inotropic therapy
•	cardiogenic shock
•	second- or third-degree AV block (without a pacemaker)
•	sick sinus syndrome
•	sinoatrial block
•	symptomatic bradycardia with less than 60 beats per minute at the beginning of therapy
•	severe bronchial asthma 
•	late stages of peripheral arterial occlusive disease or Raynaud's syndrome
•	untreated pheochromocytoma (see section 4.4)
•	metabolic acidosis
•	severe renal impairment with oliguria or anuria (creatinine clearance less than 30 ml/min and/or serum creatinine more than 1.8 mg/100 ml)
•	acute glomerulonephritis
•	coma and hepatic precoma
•	refractory hypokalaemia
•	severe hyponatraemia
•	hypercalcaemia
•	gout
•	known hypersensitivity to bisoprolol, hydrochlorothiazide or other thiazides, sulphonamides or any of the other excipients (see section 6.1)

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Therapy with Concor plus must not be stopped abruptly, particularly in patients with coronary heart disease, as this may lead to transitory deterioration of the patient&#39;s state of health (see section 4.2).</p><p dir="ltr">&nbsp;</p><p dir="ltr">Particularly close monitoring by the physician is necessary in:</p><p dir="ltr">&nbsp;</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; heart failure (in patients with concomitant stable chronic heart failure, treatment must be initiated with bisoprolol as single agent using the recommended titration phase)</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; bronchospasm (bronchial asthma, obstructive airways diseases)</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; concomitant treatment with inhalation anaesthetics</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; diabetes mellitus with large fluctuations in blood glucose values; symptoms of hypoglycaemia can be masked</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; strict fasting</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ongoing desensitisation therapy</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; first degree AV block</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Prinzmetal&rsquo;s angina</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; peripheral arterial occlusive disease (aggravation of complaints may occur especially when starting therapy)</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; hypovolaemia</p><p dir="ltr">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; impaired liver function</p><p dir="ltr">Although cardio selective (beta1) beta-blockers may have less effect on lung function than non-selective beta-blockers, as with all beta-blockers, these should be avoided in patients with obstructive airways diseases, unless there are compelling clinical reasons for their use. Where such reasons exist, Concor plus may be used with caution. In bronchial asthma or other chronic obstructive pulmonary dysfunction that may be associated with symptoms, concomitant bronchodilator therapy is indicated. An increase in airway resistance may occasionally occur in asthma patients, requiring a higher dose of &szlig;<sub>2</sub>&ndash; sympathomimetics.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Metabolic alkalosis may worsen due to the disturbed fluid and electrolyte balance.</p><p dir="ltr">&nbsp;</p><p dir="ltr">As with other beta-blockers, bisoprolol may increase both the sensitivity towards allergens and the severity of anaphylactic reactions. This applies also to ongoing desensitization therapy. Adrenaline does not always produce the desired therapeutic effect in these cases.</p><p dir="ltr">&nbsp;</p><p dir="ltr">In patients with psoriasis or with a history of psoriasis, beta- blockers (e.g. bisoprolol) should only be prescribed if the risk-to-benefit ratio has been carefully weighed.</p><p dir="ltr">&nbsp;</p><p dir="ltr">In patients with pheochromocytoma beta-blockers (e.g. bisoprolol) must not be administered until after alpha-receptor blockade.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Under treatment with beta-blockers (e.g. bisoprolol) the symptoms of thyrotoxicosis may be masked.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Acute cholecystitis has been reported in patients with cholelithiasis.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Disturbances of the electrolyte and fluid balance</em></p><p dir="ltr"><em>&nbsp;</em></p><p dir="ltr">Due to the hydrochlorothiazide component, long-term treatment with Concor 5 plus or Concor 10 plus may lead to disturbances of the electrolyte and fluid balance, in particular hypokalemia and hyponatremia, also hypomagnesaemia, hypochloridemia as well as hypercalcemia.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Hypokalemia facilitates the development of severe arrhythmia, in some cases torsade de pointes, which may be fatal.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Patients with hyperuricemia have a higher risk of gout.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Hydrochlorothiazide can cause an idiosyncratic reaction, resulting in acute transient myopia and acute angle-closure glaucoma. Symptoms include acute onset of decreased visual acuity or ocular pain and typically occur within hours to weeks of drug initiation. Untreated acute angle-closure glaucoma can lead to permanent vision loss. The primary treatment is to discontinue hydrochlorothiazide as rapidly as possible.</p><p dir="ltr">&nbsp;</p><p dir="ltr">During long-term therapy with Concor 5 plus or Concor 10 plus, the serum electrolytes (especially potassium, sodium, calcium), creatinine and urea, blood lipids (cholesterol and triglycerides), uric acid and blood glucose should be monitored regularly.</p><p dir="ltr">Hydrochlorothiazide can cause an idiosyncratic reaction, resulting in acute transient myopia and acute angle-closure glaucoma. Symptoms include acute onset of decreased visual acuity or ocular pain and typically occur within hours to weeks of drug initiation. Untreated acute angle-closure glaucoma can lead to permanent vision loss. The primary treatment is to discontinue hydrochlorothiazide as rapidly as possible.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Note:</p><p dir="ltr">&nbsp;</p><p dir="ltr">During treatment with Concor 5 plus or Concor 10 plus patients should ensure an adequate supply of fluid and food rich in potassium (e.g. bananas, vegetables, nuts) to compensate for the increased loss of potassium. The potassium losses may be reduced or prevented by concomitant therapy with potassium-sparing diuretics.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>General anesthesia</em></p><p dir="ltr">&nbsp;</p><p dir="ltr">In patients undergoing general anesthesia, beta-blockers reduce the incidence of arrythmia and myocardial ischemia during induction, intubation, and postoperatively. It is currently recommended that ongoing beta-blocker therapy should not be interrupted in case of surgery. The anesthetist must be informed that the patient is being treated with beta-blockers as this may lead to potential interactions with other pharmaceuticals, bradyarrhythmia, attenuation of reflex tachycardia and compensation of blood loss due to reduced reflex reactions. If discontinuation of beta-blocker therapy prior to surgery is necessary, treatment should be tapered gradually and be discontinued altogether about 48 hours prior to anesthesia.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Photosensitivity reactions may occur in connection with thiazide diuretics. Should photosensitivity reaction occur, exposed body areas are best protected against sun or UVA rays. In severe cases it may become necessary to discontinue therapy with Concor plus.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Non-melanoma skin cancer</p><p dir="ltr">An increased risk of non-melanoma skin cancer (NMSC) [basal cell carcinoma (BCC) and squamous cell carcinoma (SCC)] with increasing cumulative dose of hydrochlorothiazide (HCTZ) exposure has been observed in two epidemiological studies based on the Danish National Cancer Registry. Photosensitizing actions of HCTZ could act as a possible mechanism for NMSC.</p><p dir="ltr">Patients taking HCTZ should be informed of the risk of NMSC and advised to regularly check their skin for any new lesions and promptly report any suspicious skin lesions. Possible preventive measures such as limited exposure to sunlight and UV rays and, in case of exposure, adequate protection should be advised to the patients in order to minimize the risk of skin cancer. Suspicious skin lesions should be promptly examined potentially including histological examinations of biopsies. The use of HCTZ may also need to be reconsidered in patients who have experienced previous NMSC (see also section 4.8).</p><p dir="ltr">&nbsp;</p><p dir="ltr">Use of Concor plus may give positive results in doping tests.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr"><em>General information:</em></p><p dir="ltr">&nbsp;</p><p dir="ltr">It should be considered that due to serum potassium disturbances certain medicinal products may be affected.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Concomitant administration with the following is not recommended:</em></p><p dir="ltr"><em>&nbsp;</em></p><p dir="ltr">Calcium antagonists of the verapamil type and to a lesser extent those of the diltiazem type: Negative influence on contractility and atrio-ventricular conduction. In patients under beta-blocker therapy, intravenous administration of calcium antagonists of the verapamil type may lead to pronounced hypotension and AV blockade.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Centrally acting antihypertensive agents such as clonidine and others (e.g. methyldopa, moxonodine, reserpine): Combination therapy with centrally acting antihypertensives may lead to deterioration of heart failure due to reduction of the central sympathetic tone (reduction of pulse rate and ejection fraction, vasodilatation). Abrupt discontinuation, particularly prior to termination of beta-blockade may increase the risk of rebound hypertension.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Lithium: Concor 5 plus or Concor 10 plus may potentiate the cardiotoxic and neurotoxic effect of lithium through reduced lithium excretion.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Concomitant administration with the following, only with caution:</em></p><p dir="ltr"><em>&nbsp;</em></p><p dir="ltr">Calcium antagonists of the dihydropyridine type (e.g. nifedipine, amlodipine): In concomitant administration, the risk of hypotension and impairment of ventricular pumping function in heart failure patients cannot be excluded.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Tricyclic antidepressants, barbiturates, phenothiazines as well as other antihypertensives: Increased hypotensive effect.</p><p dir="ltr">&nbsp;</p><p dir="ltr">ACE inhibitors (e.g. captopril, enalapril), angiotensin II antagonists: In patients with preexisting sodium depletion and especially in patients with renal arterial stenosis, significant fall in blood pressure and/or acute renal impairment is possible upon initiation of therapy with ACE inhibitors. In sodium depletion resulting from diuretic therapy, the diuretic agent should either be discontinued three days before starting therapy with an ACE inhibitor or initiate ACE inhibitor therapy at a low dose with a gradual increase of dosage.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Class I antiarrhythmics (e.g. disopyramide, quinidine, lidocaine, phenytoin, flecainide, propafenone): Effect on atrio-ventricular conduction time may be potentiated and negative inotropic effect increased.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Class III antiarrhythmics (e.g. amiodarone): Effect on atrio-ventricular conduction time may be potentiated.</p><p dir="ltr">Antiarrhythmic drugs may produce torsade de pointes: class IA agents (e.g. quinidine, disopyramide) and class III (e.g. amiodarone and sotalol). Hypokalaemia may facilitate the occurrence of torsade de pointes. Hypokalaemia has to be avoided and, if necessary, corrected. Monitor the QT interval. In case of torsade de pointes no antiarrhythmics should be administered (pace maker therapy).</p><p dir="ltr">&nbsp;</p><p dir="ltr">Non anti-arrhythmic agents that may induce torsade de pointes: Astemizole, i.v. erythromycin, halofantrine, pentamidine, sparfloxazin, terfenadine and vincamine. Hypokalaemia may facilitate the occurrence of torsade de pointes. In case of hypokalaemia medicinal products that do not induce torsade, de pointes are to be used.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Parasympathomimetic drugs: Concomitant use may increase atrio-ventricular conduction time and increase the risk of bradycardia.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Topical application of beta-blockers (e.g. as in eyedrops for glaucoma treatment) may enhance the systemic effect of bisoprolol.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Insulin and oral antidiabetic agents: Increase of blood sugar lowering effect. Blockade of beta-adrenoreceptors may mask symptoms of hypoglycaemia.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Anaesthetic agents: Attenuation of reflex tachycardia and increased risk of hypotension (see also section 4.4).</p><p dir="ltr">&nbsp;</p><p dir="ltr">Digitalis glycosides: Increase of atrio-ventricular conduction time, reduction in heart rate. . If hypokalaemia and/or hypomagnesaemia develop during treatment with Concor 5 plus or Concor 10 plus the myocardium may show increased sensitivity to cardiac glycosides, leading to an enhanced effect and adverse effects of the glycosides.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Non-steroidal antiphlogistic (NSAIDs): Decreased hypotensive effect.</p><p dir="ltr">In patients developing hypovolemia the concomitant administration of nonsteroidal anti-inflammatory drugs can trigger acute renal failure.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Beta-sympathomimetic drugs: Combination with bisoprolol may reduce the effect of both agents. Higher doses of adrenaline may be required for treatment of allergic reactions.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Sympathomimetic drugs that activate alpha- and beta-receptors (e.g. adrenaline, noradrenaline): Potential increase in blood pressure and exacerbated intermittent claudication. Such interactions are more likely in non-selective beta-blockers.</p><p dir="ltr">&nbsp;</p><p dir="ltr">The effect of uric acid lowering agents may be attenuated in concomitant use of Concor 5 plus or Concor 10 plus.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Potassium losses may be increased by concomitant use of Concor 5 plus or Concor 10 plus and glucocorticoids, ACTH, carbenoxolone, amphotericin B, furosemide or laxatives.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Cholestyramine, colestipol: Reduced absorption of the hydrochlorothiazide component of Concor 5 plus or Concor 10 plus.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Methyldopa: Hemolysis due to the formation of antibodies to hydrochlorothiazide has been described in isolated cases.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Notes to be taken into account in concomitant administration with the following:</em></p><p dir="ltr">&nbsp;</p><p dir="ltr">Corticosteroids: Reduced antihypertensive effect.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Mefloquine: Increased risk of bradycardia.</p><p dir="ltr">Monoamine oxidase inhibitors (except MAO-B inhibitors): Enhanced hypotensive effect of the beta-blocker but also risk of hypertensive crisis.</p><p dir="ltr">&nbsp;</p><p dir="ltr">In high-dose salicylate administration the toxic effect of salicylates on the central nervous system may be intensified</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr"><em>Pregnancy</em></p><p dir="ltr">&nbsp;</p><p dir="ltr">Bisoprolol has pharmacological effects that may cause harmful effects on pregnancy and/or the foetus/new-born. In general, beta-adrenoceptor blockers reduce placental perfusion, which has been associated with growth retardation, intrauterine death, abortion or early labour. Adverse effects (e.g. hypoglycaemia and bradycardia) may occur in the foetus and new-born infant. If treatment with beta-adrenoceptor blocker is necessary, beta<sub>1</sub>-selective adrenoceptor blockers are preferable.</p><p dir="ltr">&nbsp;</p><p dir="ltr">There is limited experience with hydrochlorothiazide during pregnancy, especially during the first trimester. Animal studies are insufficient.</p><p dir="ltr">Hydrochlorothiazide crosses the placenta. Based on the pharmacological mechanism of action of hydrochlorothiazide its use during the second and third trimester may compromise foeto-placental perfusion and may cause fetal and neonatal effects like icterus, disturbance of electrolyte balance and thrombocytopenia.</p><p dir="ltr">Hydrochlorothiazide should not be used for gestational edema, gestational hypertension or preeclampsia due to the risk of decreased plasma volume and placental hypoperfusion, without a beneficial effect on the course of the disease.</p><p dir="ltr">Hydrochlorothiazide should not be used for essential hypertension in pregnant women except in rare situations where no other treatment could be used.</p><p dir="ltr">&nbsp;</p><p dir="ltr">The administration of Concor 5 plus or Concor 10 plus is not recommended during pregnancy as a thiazide diuretic is contained.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Lactation</em></p><p dir="ltr">&nbsp;</p><p dir="ltr">Bisoprolol fumarate may be secreted into human breast milk. Hydrochlorothiazide is secreted in a limited amount into human breast milk. Thiazide diuretics, used in high doses for intensive diuresis, can inhibit the milk production. The administration of Concor 5 plus or Concor 10 plus is not recommended during lactation.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Fertility</em></p><p dir="ltr"><em>&nbsp;</em></p><p dir="ltr">No human data on fertility are known for the combination product. Bisoprolol or hydrochlorothiazide had no influence on fertility or on general reproduction performance in animal studies.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Concor 5 plus or Concor 10 plus has no or negligible influence on the ability to drive and to use machines. Due to individually varying reactions to the medicinal product the ability to drive a vehicle or to use machines may be impaired.</p><p dir="ltr">&nbsp;</p><p dir="ltr">This should be considered particularly at the start of therapy and upon change of medication, as well as in conjunction with alcohol.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">The assessment of adverse reactions is based on the following frequency grouping:</p><p dir="ltr">&nbsp;</p><p dir="ltr">Common:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &ge;1/100 to &lt;1/10</p><p dir="ltr">Uncommon:&nbsp;&nbsp;&nbsp;&nbsp; &ge;1/1,000 to &lt;1/100</p><p dir="ltr">Rare:&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &ge;1/10,000 to &lt;1/1,000</p><p dir="ltr">Very rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &lt;1/10,000,</p><p dir="ltr">not known (cannot be estimated from the available data)</p><p dir="ltr"><em>&nbsp;</em></p><p dir="ltr"><strong><em>Neoplasms benign, malignant and unspecified (incl cysts and polyps): </em></strong></p><p dir="ltr">Not known: Non-melanoma skin cancer (Basal cell carcinoma and Squamous cell carcinoma).</p><p dir="ltr"><strong><em>Blood and lymphatic system disorders:</em></strong></p><p dir="ltr">&nbsp;</p><p dir="ltr">Rare &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Leucopenia, thrombocytopenia</p><p dir="ltr">Very rare &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Agranulocytosis</p><p dir="ltr"><strong><em>&nbsp;</em></strong></p><p dir="ltr"><strong><em>Psychiatric disorders:</em></strong></p><p dir="ltr">&nbsp;</p><p dir="ltr">Uncommon &nbsp;&nbsp;&nbsp;&nbsp; Sleep disorders, depression</p><p dir="ltr">Rare &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Nightmares, hallucinations</p><p dir="ltr">&nbsp;</p><p dir="ltr"><strong><em>Metabolism and nutrition disorders:</em></strong></p><p dir="ltr">&nbsp;</p><p dir="ltr">Common&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hyperglycaemia, hyperuricaemia, disturbances of the fluid and electrolyte balance (in particular hypokalaemia and hyponatraemia, also hypomagnesaemia and hypochloridaemia as well as hypercalcaemia)</p><p dir="ltr">Uncommon&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Loss of appetite</p><p dir="ltr">Very rare&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Metabolic alkalosis</p><p dir="ltr">&nbsp;</p><p dir="ltr"><strong><em>Nervous system disorders:</em></strong></p><p dir="ltr">&nbsp;</p><p dir="ltr">Common&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dizziness*, headache*</p><p dir="ltr">&nbsp;</p><p dir="ltr"><strong><em>Eye disorders:</em></strong></p><p dir="ltr">&nbsp;</p><p dir="ltr">Rare &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reduced tear flow (to be taken into consideration in patients wearing contact lenses), visual disturbances</p><p dir="ltr">Very rare &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Conjunctivitis</p><p dir="ltr">Not known:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Choroidal effusion, angle-closure glaucoma</p><p dir="ltr"><strong><em>&nbsp;</em></strong></p><p dir="ltr"><strong><em>Ear and labyrinth disorders:</em></strong></p><p dir="ltr">&nbsp;</p><p dir="ltr">Rare &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hearing disorders</p><p dir="ltr"><strong><em>&nbsp;</em></strong></p><p dir="ltr"><strong><em>Cardiac disorders:</em></strong></p><p dir="ltr">&nbsp;</p><p dir="ltr">Uncommon&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bradycardia, AV-conduction disturbances, deterioration of existing heart failure</p><p dir="ltr">&nbsp;</p><p dir="ltr"><strong><em>Vascular disorders:</em></strong></p><p dir="ltr">&nbsp;</p><p dir="ltr">Common&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Sensation of cold or numb extremities</p><p dir="ltr">Uncommon<strong><em>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em></strong>Orthostatic dysregulation</p><p dir="ltr">Rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Syncope</p><p dir="ltr"><strong><em>&nbsp;</em></strong></p><p dir="ltr"><strong><em>Respiratory, thoracic and mediastinal disorders:</em></strong></p><p dir="ltr">&nbsp;</p><p dir="ltr">Uncommon &nbsp;&nbsp;&nbsp;&nbsp; Bronchospasm in patients with a history of bronchial asthma or obstructive airways disease</p><p dir="ltr">Rare &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Allergic rhinitis</p><p dir="ltr">Not known: &nbsp;&nbsp;&nbsp;&nbsp; Interstitial lung disease</p><p dir="ltr"><em>&nbsp;</em></p><p dir="ltr"><strong><em>Gastrointestinal disorders:</em></strong></p><p dir="ltr"><strong><em>&nbsp;</em></strong></p><p dir="ltr">Common &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Nausea, vomiting, diarrhoea, constipation</p><p dir="ltr">Uncommon&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Abdominal ailments, pancreatitis</p><p dir="ltr"><strong><em>&nbsp;</em></strong></p><p dir="ltr"><strong><em>Hepatobilary disorders:</em></strong></p><p dir="ltr"><strong><em>&nbsp;</em></strong></p><p dir="ltr">Rare &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hepatitis, jaundice</p><p dir="ltr">&nbsp;</p><p dir="ltr"><strong><em>Skin and subcutaneous tissue disorders:</em></strong></p><p dir="ltr">&nbsp;</p><p dir="ltr">Rare&nbsp;&nbsp;&nbsp;&nbsp; Hypersensitivity reactions (pruritus, flush, rash, photodermatitis, purpura, urticaria and</p><p dir="ltr">angioedema)</p><p dir="ltr">Very rare&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Beta-blockers can trigger psoriasis, aggravate the condition or lead to psoriasiform rash, hair loss or cutaneous lupus erythematosus</p><p dir="ltr"><strong><em>&nbsp;</em></strong></p><p dir="ltr"><strong><em>Musculoskeletal and connective tissue disorders:</em></strong></p><p dir="ltr"><strong><em>&nbsp;</em></strong></p><p dir="ltr">Uncommon &nbsp;&nbsp;&nbsp;&nbsp; Muscle weakness and cramps</p><p dir="ltr"><strong><em>&nbsp;</em></strong></p><p dir="ltr"><strong><em>Reproductive system and breast disorders: </em></strong></p><p dir="ltr"><strong><em>&nbsp;</em></strong></p><p dir="ltr">Rare&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; erectile dysfunction</p><p dir="ltr">&nbsp;</p><p dir="ltr"><strong><em>General disorders and administration site conditions:</em></strong></p><p dir="ltr">&nbsp;</p><p dir="ltr">Common&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fatigue*</p><p dir="ltr">Uncommon &nbsp;&nbsp;&nbsp;&nbsp; Asthenia</p><p dir="ltr">Very rare&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Chest pain</p><p dir="ltr">&nbsp;</p><p dir="ltr"><strong><em>Investigations:</em></strong></p><p dir="ltr">&nbsp;</p><p dir="ltr">Common&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Increased triglyceride and cholesterin levels, glucosuria</p><p dir="ltr">Uncommon&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Increase in amylase, reversible increase in serum creatinine and urea</p><p dir="ltr">Rare&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Increase in liver enzymes (ASAT, ALAT)</p><p dir="ltr">&nbsp;</p><p dir="ltr">*These symptoms occur especially at the start of treatment. They are generally mild and mostly disappear within 1-2 weeks.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><strong><em>Description of selected adverse reactions </em></strong></p><p dir="ltr">Non-melanoma skin cancer: Based on available data from epidemiological studies, cumulative dose-dependent association between HCTZ and NMSC has been observed (see also sections 4.4 and 5.1).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">The signs of overdosage are bradycardia, hypotension, bronchospasm, acute heart failure, hypoglycemia and conduction disturbances in ECG recording. There is a wide inter-individual variation in sensitivity to one single high dose of bisoprolol, and patients with heart failure are probably very sensitive.</p><p dir="ltr">Bradycardia caused by overdose is treated with atropine (1 &ndash; 2 mg i.v.), isoprenaline or with a temporary pacemaker. The decrease in blood pressure is treated with intravenous volume replacement and, if necessary, with vasoconstrictive acting catecholamines.</p><p dir="ltr">Bronchospasm can be treated with theophylline, theophylline-derivates or &szlig;-sympathomimetics. If only a short time (0-2 h) has passed since overdose, active charcoal is given to the patient and gastric lavage is to be considered. Heart rate, blood pressure, electrolyte balance and blood glucose must be monitored. The elimination of bisoprolol cannot be significantly increased by hemodialysis.</p><p dir="ltr">&nbsp;</p><p dir="ltr">The clinical picture in acute or chronic overdose of hydrochlorothiazide is characterized by the extent of fluid and electrolyte loss. Most common signs are dizziness, nausea, somnolence, hypovolemia, hypotension, hypokalemia.</p><p dir="ltr">&nbsp;</p><p dir="ltr">No sufficient data is available on the efficacy of hemodialytic elimination of hydrochlorothiazide</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Pharmacotherapeutic group: Selective beta-blocker and thiazide diuretic</p><p dir="ltr">ATC code: C07BB07</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Bisoprolol</em></p><p dir="ltr"><em>&nbsp;</em></p><p dir="ltr">Bisoprolol is a beta-blocker that holds an intermediate position with regard to lipophilia and hydrophilia. Bisoprolol is a highly selective cardioactive beta<sub>1</sub>-blocker without any intrinsic sympathomimetic activity nor clinically relevant membrane-stabilizing effect. Bisoprolol depresses the response to sympathoadrenergic activity through blockade of cardiac beta-receptors. This causes a decrease in heart rate and in contractility and thus a reduction of myocardial oxygen consumption.</p><p dir="ltr"><em>&nbsp;</em></p><p dir="ltr"><em>Hydrochlorothiazide</em></p><p dir="ltr">&nbsp;</p><p dir="ltr">Hydrochlorothiazide is a benzothiadiazine derivative which primarily increases electrolyte excretion and secondarily enhances urinary flow by osmotically bound water.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Hydrochlorothiazide inhibits predominantly sodium absorption in the distal tubule, so that maximally about 15% of the sodium undergoing glomerular filtration can be excreted. The extent of chloride excretion roughly corresponds to that of sodium excretion.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Hydrochlorothiazide also causes an increase in potassium excretion which is essentially determined by the potassium secretion in the distal tubule and in the collecting tube (increased exchange between sodium and potassium ions). The saliuretic or diuretic effect of hydrochlorothiazide is not influenced to any appreciable extent by acidosis or alkalosis.</p><p dir="ltr">&nbsp;</p><p dir="ltr">The glomerular filtration rate is initially diminished to a slight extent. During long-term therapy with hydrochlorothiazide, the calcium excretion via the kidneys is reduced so that hypercalcemia may result.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Hydrochlorothiazide relaxes smooth vascular muscles and thus reduces peripheral resistance.</p><p dir="ltr">&nbsp;</p><p dir="ltr">In patients with chronic renal impairment (creatinine clearance less than 30&nbsp;ml/min and/or serum creatinine above 1.8 mg/100 ml) hydrochlorothiazide is practically ineffective. In patients with renal and ADH-sensitive diabetes insipidus, hydrochlorothiazide has an antidiuretic effect.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Non-melanoma skin cancer: Based on available data from epidemiological studies, cumulative dose-dependent association between HCTZ and NMSC has been observed. One study included a population comprised of 71,533 cases of BCC and of 8,629 cases of SCC matched to 1,430,833 and 172,462 population controls, respectively. High HCTZ use (&ge;50,000 mg cumulative) was associated with an adjusted OR of 1.29 (95% CI: 1.23-1.35) for BCC and 3.98 (95% CI: 3.68-4.31) for SCC. A clear cumulative dose response relationship was observed for both BCC and SCC. Another study showed a possible association between lip cancer (SCC) and exposure to HCTZ: 633 cases of lip-cancer were matched with 63,067 population controls, using a risk-set sampling strategy. A cumulative dose-response relationship was demonstrated with an adjusted OR 2.1 (95% CI: 1.7-2.6) increasing to OR 3.9 (3.0-4.9) for high use (~25,000 mg) and OR 7.7 (5.7-10.5) for the highest cumulative dose (~100,000 mg) (see also section 4.4).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr"><em>Bisoprolol</em></p><p dir="ltr">&nbsp;</p><p dir="ltr">About 90% of bisoprolol is bioavailable from film-coated tablets. After intake bisoprolol is absorbed almost completely (&gt; 90%) from the gastrointestinal tract. Along with the very low first-pass effect in</p><p dir="ltr">the liver (&lt; 10%) this results in an absolute bioavailability of 88%. Bisoprolol may be taken on an empty stomach as well as with breakfast without any change in absorption or bioavailability. Bisoprolol has a plasma protein binding of about 30%. Pathophysiological changes in plasma proteins, e.g. alpha<sub>1</sub>-glycoproteins, do not affect the pharmacokinetics of bisoprolol. Peak plasma concentrations are usually measured 1-3 hours after administration. With its only moderate lipophilia and low plasma protein binding, the distribution volume of bisoprolol is 226 &plusmn; 11 l (x &plusmn; SEM).</p><p dir="ltr">&nbsp;</p><p dir="ltr">Bisoprolol is removed from the body by two equally effective clearance routes with 50% being metabolized by the liver to inactive metabolites which are then renal excreted. The remaining 50% are excreted unmetabolized via the kidneys. Bisoprolol is eliminated from the plasma with a half-life of 10-12 hours. Related to Cmax and AUC of bisoprolol in steady state there is bioequivalence between the fixed combination with hydrochlorothiazide and the single agent.</p><p dir="ltr"><em>Hydrochlorothiazide</em></p><p dir="ltr"><em>&nbsp;</em></p><p dir="ltr">After oral administration about 80% of hydrochlorothiazide is absorbed from the gastrointestinal tract. The systemic availability is 71 &plusmn; 15%.</p><p dir="ltr">The plasma protein binding of hydrochlorothiazide is 64%; the relative volume of distribution is 0.5-1.1 l/kg.</p><p dir="ltr">&nbsp;</p><p dir="ltr">In healthy humans more than 95% of hydrochlorothiazide is excreted via the kidneys as unchanged substance.</p><p dir="ltr">With normal kidney function the elimination half-life is 2.5 hours. Peak plasma concentrations are usually measured after 2-5 hours. This period increases in the presence of impaired kidney function and is about 20 hours in patients with terminal renal impairment.</p><p dir="ltr">&nbsp;</p><p dir="ltr">The diuretic effect sets in within 1-2 hours and lasts for 10-12 hours depending on the dose; the antihypertensive effect lasts for up to 24 hours</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Conventional preclinical toxicity studies (chronic toxicity, mutagenicity, genotoxicity or carcinogenicity) did not reveal any harmful effects on humans caused by bisoprolol and hydrochlorothiazide. Like other beta-blockers, high doses of bisoprolol caused maternal (decreased food intake and weight loss) and embryonal/fetal toxicity (increased incidence of resorptions, reduced birth weight of the newborn, retarded physical development up to the end of the nursing period). Bisoprolol and hydrochlorothiazide were, however, not teratogenic. There was no increase in toxicity when both components were given in combination.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Tablet core:</p><p dir="ltr">&nbsp;</p><p dir="ltr">Silica colloidal anhydrous 0.50 mg</p><p dir="ltr">Magnesium stearate 2.00 mg</p><p dir="ltr">Cellulose microcrystalline 10.00 mg</p><p dir="ltr">Maize starch 10.00 mg</p><p dir="ltr">Calcium hydrogen phosphate anhydrous 130 mg</p><p dir="ltr">Iron oxide red 0.00438 mg</p><p dir="ltr">Iron oxide black 0.00600 mg</p><p dir="ltr">Dimeticone (100) 0.02450 mg</p><p dir="ltr">Macrogol (400) 0.53 mg</p><p dir="ltr">Titanium dioxide 1.21 mg</p><p dir="ltr">Hypromellose (2910)&nbsp; 2.20 mg</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                3 YEARS 
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Do not store above 30&deg;C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Blister pack made of a PVC base film and an aluminum cover foil.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Package sizes:&nbsp; 30, 50, 100 film-coated tablets, hospital pack</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">No special requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Merck Healthcare KGaA
Frankfurter Strasse 250
64293 Darmstadt
Darmstadt
Germany

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                November 2020
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>